Triethylamine → 4-[4-(4,5-dihydro-3-phenyl-5-isoxazolyl)-2-thiazolyl]-1-[(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetyl]piperidine
Reaction equation
[CH:1](=[N:8][OH:9])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.ClN1C(=O)CCC1=O.[CH:18]([C:20]1[N:21]=[C:22]([CH:25]2[CH2:30][CH2:29][N:28]([C:31](=[O:43])[CH2:32][N:33]3[C:37]([CH3:38])=[CH:36][C:35]([C:39]([F:42])([F:41])[F:40])=[N:34]3)[CH2:27][CH2:26]2)[S:23][CH:24]=1)=[CH2:19].C(N(CC)CC)C>CN(C)C=O.O>[C:2]1([C:1]2[CH2:19][CH:18]([C:20]3[N:21]=[C:22]([CH:25]4[CH2:30][CH2:29][N:28]([C:31](=[O:43])[CH2:32][N:33]5[C:37]([CH3:38])=[CH:36][C:35]([C:39]([F:41])([F:40])[F:42])=[N:34]5)[CH2:27][CH2:26]4)[S:23][CH:24]=3)[O:9][N:8]=2)[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of benzaldehyde oxime (49 mg, 0.4 mmol) in N,N-dimethylformamide (3 mL) was added N-chlorosuccinimide (54 mg, 0.4 mmol), followed by addition of 4-(4-ethenyl-2-thiazolyl)-1-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]piperidine (i.e. the product of Example 4, Step C) (103 mg, 0.27 mmol) and triethylamine (41 mg, 0.4 mmol). The resulting mixture was stirred at room temperature for 5 h, then diluted with water, extracted with dichloromethane (2×). The organic layers were combined and dried (MgSO4), and filtered. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using 55-70% ethyl acetate in hexanes as eluant to give 90 mg of the title product, a compound of the present invention as a white solid.
Workup
- extractionextracted with dichloromethane (2×)
- dry with materialdried (MgSO4)
- filtrationfiltered
- concentrationThe filtrate was concentrated
- customthe residue was purified by column chromatography on silica gel using 55-70% ethyl acetate in hexanes as eluant
Sources & evidence
- ORD record
- ord-6fd48b9f551b4b158331a284fad7772f
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08642634B2
Reaction notes
Loading…